Vista Pharmaceuticals hits 10% upper circuit
The company already filed a complex ANDA in September 2017, targeting Cardiology segment with a market size of $200 million (Rs1,360cr) as per latest IMS data.from India Infoline News Service https://ift.tt/2xl9kbH
Comments
Post a Comment